KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
72 hedge funds and large institutions have $121M invested in Kinnate Biopharma Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
55% less capital invested
Capital invested by funds: $270M → $121M (-$149M)
Holders
72
Holding in Top 10
5
Calls
$72K
Puts
$6K
Top Buyers
| 1 | +$8.68M | |
| 2 | +$4.7M | |
| 3 | +$2.73M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.22M |
| 5 |
Renaissance Technologies
New York
|
+$689K |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$7.25M | |
| 3 | -$6.81M | |
| 4 |
BlackRock
New York
|
-$4.71M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.95M |